You Position: Home > Paper

Clinical Study of Matrix Metalloproteinase-9 and transforming growth factor-β1 related with diabetic nephropathy

( views:331, downloads:29 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF DIABETES
Issue:
5
DOI:
10.3321/j.issn:1006-6187.2003.05.005
Key Word:
基质金属蛋白酶-9;转化生长因子β1;IV型胶原;糖尿病肾病;Diabetic nephropathy

Abstract: Objective To study whether serum matrix metalloproteinase 9, serum transforming growth factor β 1, serum type C IV collagen concentrations are alternatoin in various stages of patients with T2DM. Methods 64 cases T2DM patients were divided into three groups according to urine albumin excretion rate (UAER):normoalbuminuria (NA)group and microalbuminuria (MA) group and overt diabetic nephropathy (ODN)group. Serum MMP 9,TGF β 1 and C IV were detected in all cases. Results Serum MMP 9 in MA and ODN groups were higher than NA and normal control groups ( P <0.01);Serum TGF β 1 in NA,MA and ODN groups were higher than NC group( P <0.01); Serum C IV in ODN group was higher than other three groups( P <0.01)。 Conclusion Higher Serum MMP 9、TGF β 1 plays an important role in the development of diabetic nephropathy in T2DM.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn